Phase I Drug Combination Trial Design: Walking the Tightrope
Authors:
- 20 September 2009
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (27) , 4441-4443
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Phase I Study of C-TPF in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and NeckJournal of Clinical Oncology, 2009
- Recent Advances in Head and Neck CancerNew England Journal of Medicine, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic RegimensJournal of Clinical Oncology, 2005
- Phase I Pharmacologic Study of Oral Topotecan and Intravenous Cisplatin: Sequence-Dependent Hematologic Side EffectsJournal of Clinical Oncology, 2000